RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest

Eliska Vaclavikova1, Sarka Dvorakova, Vlasta Sykorova

  • 1Department of Molecular Endocrinology, Institute of Endocrinology, Narodni 8, 116 94, Prague 1, Czech Republic. evaclavikova@endo.cz

Endocrine
|October 15, 2009
PubMed

Insights

The RET proto-oncogene Tyr791Phe mutation shows varied clinical effects, appearing in both gain-of-function (medullary thyroid carcinoma) and loss-of-function (Hirschsprung

Area of Science:

  • Genetics
  • Oncology
  • Endocrinology

Background:

  • Activating RET proto-oncogene mutations are linked to familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A/2B.
  • Inactivating RET mutations are associated with Hirschsprung's disease (HSCR).
  • The Tyr791Phe mutation in RET exon 13 is frequently discussed for its role in these conditions.

Observation:

  • Screening of 276 FMTC/MTC, 122 HSCR, and 29 pheochromocytoma families identified the Tyr791Phe mutation in sporadic MTC, FMTC/MEN2, pheochromocytoma, and HSCR.
  • All Tyr791Phe carriers also possessed the Leu769Leu polymorphism in exon 13.
  • Second germline mutations (Cys620Phe, Met918Thr, Ser649Leu) were found in three families.

Findings:

  • The Tyr791Phe mutation was detected in patients with medullary thyroid carcinoma (MTC), multiple endocrine neoplasia (MEN) types 2A/2B, pheochromocytoma, and Hirschsprung's disease (HSCR).
  • This suggests the Tyr791Phe mutation may possess dual gain-of-function and loss-of-function characteristics.
  • A rare malignant pheochromocytoma case associated with Tyr791Phe is presented.

Implications:

  • The study highlights the diverse clinical manifestations associated with the RET Tyr791Phe mutation.
  • Understanding these genotype-phenotype correlations is crucial for accurate diagnosis and genetic counseling.
  • Further research is needed to fully elucidate the dual functional capacity of this RET mutation.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mutations01:39

Mutations

Overview
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...